CUMC Home | Columbia University | Jobs at CUMC | Contact CUMC | Find People
     
Columbia University Medical Center logo,Positioning Line Discover. Educate. Care. Lead., image for New York Skyline  
 

The Dean's Lecture Series
Alexander Ming Fisher Lecture

Dean's Distinguished Lecture in the Basic Sciences

The Cartwright Lecture

Dean's Distinguished Lecture in the Clinical Sciences

David Seegal Alpha Omega Alpha Visiting Professorship Lecture

Heidelberger-Kabat Lecture

Dean's Distinguished Lecture in the Humanities

Innovation in Biological and Medical Sciences Distinguished Lecture
past events

Louisa Gross Horwitz Prize Lecture

Samuel Rudin Distinguished Visiting Professorship Lecture

Thomas Q. Morris Symposia

Other Special Lectures and Events


Previous lectures:
2003-2004
2004-2005
2005-2006
2006-2007
2007-2008
2008-2009
2009-2010
2010-2011
2011-2012
2012-2013
2013-2014
2014-2015

Lecture Videos

home


      

Innovation in Biological and Medical

Sciences Distinguished Lecture

The Innovation in Biological and Medical Sciences Distinguished Lecture was established in 2013 to highlight and profile creative and exciting work from leaders in science. This new lectureship is part of the College of Physicians & Surgeons Lecture Series, which celebrates scholarly exchanges and focuses on the collaborative nature of our scientific endeavors.



2017-2018 EVENTS

George Yancoupolos, MD, PhD

"Building A Better Biotech: The Story of Regeneron"

George Yancopoulos, MD, PhD
President and Chief Scientific Officer
Regeneron

Thursday, February 1, 2018
4:30 pm
Clyde and Helen Wu Auditorium,
Room 201
Roy and Diana Vagelos Education Center
104 Haven Avenue
Recption to follow

George D. Yancopoulos, M.D., Ph.D., joined Regeneron in 1989 as its Scientific Founder and is currently the President and Chief Scientific Officer . He received his M.D. and Ph.D. degrees in Biochemistry and Molecular Biophysics from Columbia University. In the 1990s, Dr. Yancopoulos was the 11th most highly cited scientist in the world, and in 2004 he was elected to both the National Academy of Sciences and the American Academy of Arts & Sciences. Dr. Yancopoulos, together with key members of his team, is principal inventor and developer of Regeneron's four FDA-approved drugs: PRALUENT® (alirocumab) Injection, EYLEA® (aflibercept) Injection, ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion, and ARCALYST® (rilonacept) Injection as well as of Regeneron's foundational technologies for target and drug development, such as its proprietary TRAP technology, VelociGene® and VelocImmune®. These technologies have produced Regeneron's robust pipeline of fully human antibodies targeting cholesterol-lowering efforts, rheumatoid arthritis, atopic dermatitis, asthma, pain, cancer, and infectious diseases. In 2014, Dr. Yancopoulos and his team launched the Regeneron Genetics Center, a major new initiative in human genetic research that has already sequenced exomes from more than 120,000 people.



back to top

PAST INNOVATION IN BIOLOGICAL AND MEDICAL SCIENCES LECTURERS

2014

David Goldstein, PhD
“Toward Precision Medicine in Neurodevelopmental Diseases”

2013

John Todd, FRS, FMedSci, PhD
“From Genes to Mechanism-Based Interventions in Autoimmune Disease”



back to top

CUMC Home | © Columbia University | Affiliated with New York-Presbyterian Hospital | Comments | Text-Only Version